ArticleLeukemia research reports2026

A randomized comparison of CPX-351 and FLAG-Ida in high-risk myelodysplastic syndrome: A subgroup analysis of UK NCRI AML19.

Priyanka Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.